First human tests begin for experimental brain drug
NCT ID NCT07253246
Summary
This early-stage study aims to test the safety of a new oral drug called ENX-205 in healthy volunteers. Researchers will give increasing doses to 60 participants and use brain scans to see how the drug interacts with its target. The main goal is to understand how the body processes the drug and whether it causes any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Parexel London EPCU
RECRUITINGLondon, Middlesex, HA1 3UJ, United Kingdom
Conditions
Explore the condition pages connected to this study.